| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Artimplant AB > News item |
Artimplant receives CE mark for new Artelon spacers
By E. Janene Geiss
Philadelphia, July 14 - Artimplant AB said Friday that it has received the CE mark for its Artelon STT Spacer, Artelon MTP Spacer and Artelon CMC Spacer Arthro for minimally invasive surgery.
These are three of four products under the development and license agreements with Small Bone Innovations, Inc., signed in October 2005, according to a company news release.
The fourth spacer product under that agreement, Artelon DRU Spacer, received CE mark in March.
About 1,200 patients with thumb base osteoarthritis have successfully been treated in the United States and Europe since the Artelon CMC Spacer received clearance for marketing.
Together with the recent addition of a larger CMC spacer, the new spacer products nearly double the market potential of spacer products.
This significantly contributes to establishing Artelon as the biomaterial of choice and the spacer concept as the preferred therapy for treatment of osteoarthritis in small bones and joints, Artimplant officials said.
Artimplant said it will receive milestone payments from Small Bone Innovations when regulatory approvals have been granted both for Europe and the United States.
As communicated in October 2005, total revenues to Artimplant from the four new spacer products are estimated to exceed SEK 50 million over the next five to six years.
The new spacers are intended to treat osteoarthritis - one of the most common joint diseases in the hand and foot.
The spacer preserves the anatomy and buffers the bone on bone contact that results from osteoarthritic joint degeneration.
Small Bone Innovations, based in New York, specializes in small bone and joint science.
Artimplant is a Vastra Frolunda, Sweden, biomaterials company focused on solutions to problems in orthopedic, odontological and reconstructive surgery.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.